EBR:ONWD - NL0015000HT4 - Common Stock
The current stock price of ONWD.BR is 5.12 EUR. In the past month the price increased by 22.05%. In the past year, price increased by 8.94%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABL.DE | ABBOTT LABORATORIES | 27.17 | 198.13B | ||
IUI1.DE | INTUITIVE SURGICAL INC | 57.44 | 141.67B | ||
BSX.DE | BOSTON SCIENTIFIC CORP | 37.77 | 135.43B | ||
1BSX.MI | BOSTON SCIENTIFIC CORP | 37.27 | 133.65B | ||
2M6.DE | MEDTRONIC PLC | 16.79 | 101.90B | ||
1SHL.MI | SIEMENS HEALTHINEERS AG | 19.87 | 53.35B | ||
SHL.DE | SIEMENS HEALTHINEERS AG | 19.85 | 53.29B | ||
BOX.DE | BECTON DICKINSON AND CO | 13.35 | 46.68B | ||
EWL.DE | EDWARDS LIFESCIENCES CORP | 31.72 | 40.97B | ||
DC4.DE | DEXCOM INC | 44.03 | 25.04B | ||
PHI1.DE | KONINKLIJKE PHILIPS NV | 16.53 | 22.93B | ||
PHIA.AS | KONINKLIJKE PHILIPS NV | 16.53 | 22.92B |
Onward Medical NV is a medical technology company, which engages in creating therapies to restore movement, independence, and health in people with spinal cord injury. The company is headquartered in Eindhoven, Noord-Brabant and currently employs 102 full-time employees. The company went IPO on 2021-10-21. The firm is primarily engaged in developing and commercializing innovative therapies to enable functional recovery for people with spinal cord injury. The company develops two technology platforms ARC EX and ARC IM.
ONWARD MEDICAL
Schimmelt 2
Eindhoven NOORD-BRABANT NL
Employees: 102
The current stock price of ONWD.BR is 5.12 EUR. The price decreased by -3.94% in the last trading session.
The exchange symbol of ONWARD MEDICAL is ONWD and it is listed on the Euronext Brussels exchange.
ONWD.BR stock is listed on the Euronext Brussels exchange.
10 analysts have analysed ONWD.BR and the average price target is 13.67 EUR. This implies a price increase of 166.95% is expected in the next year compared to the current price of 5.12. Check the ONWARD MEDICAL stock analysts ratings, price target forecast and up-and down grades for more detailed information.
ONWARD MEDICAL (ONWD.BR) has a market capitalization of 228.61M EUR. This makes ONWD.BR a Micro Cap stock.
ONWARD MEDICAL (ONWD.BR) currently has 102 employees.
ONWARD MEDICAL (ONWD.BR) has a support level at 4.98 and a resistance level at 5.17. Check the full technical report for a detailed analysis of ONWD.BR support and resistance levels.
The Revenue of ONWARD MEDICAL (ONWD.BR) is expected to grow by 485.44% in the next year. Check the estimates tab for more information on the ONWD.BR EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ONWD.BR does not pay a dividend.
ONWARD MEDICAL (ONWD.BR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.92).
ChartMill assigns a technical rating of 8 / 10 to ONWD.BR. When comparing the yearly performance of all stocks, ONWD.BR is one of the better performing stocks in the market, outperforming 78.43% of all stocks.
ChartMill assigns a fundamental rating of 2 / 10 to ONWD.BR. While ONWD.BR seems to be doing ok healthwise, there are quite some concerns on its profitability.
Over the last trailing twelve months ONWD.BR reported a non-GAAP Earnings per Share(EPS) of -0.92. The EPS increased by 23.37% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -46.92% | ||
ROE | -74.34% | ||
Debt/Equity | 0.3 |
10 analysts have analysed ONWD.BR and the average price target is 13.67 EUR. This implies a price increase of 166.95% is expected in the next year compared to the current price of 5.12.
For the next year, analysts expect an EPS growth of -20.73% and a revenue growth 485.44% for ONWD.BR